16-7579839-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000550418.6(RBFOX1):āc.333A>Gā(p.Glu111=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0116 in 1,614,028 control chromosomes in the GnomAD database, including 172 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0099 ( 12 hom., cov: 32)
Exomes š: 0.012 ( 160 hom. )
Consequence
RBFOX1
ENST00000550418.6 synonymous
ENST00000550418.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.79
Genes affected
RBFOX1 (HGNC:18222): (RNA binding fox-1 homolog 1) The Fox-1 family of RNA-binding proteins is evolutionarily conserved, and regulates tissue-specific alternative splicing in metazoa. Fox-1 recognizes a (U)GCAUG stretch in regulated exons or in flanking introns. The protein binds to the C-terminus of ataxin-2 and may contribute to the restricted pathology of spinocerebellar ataxia type 2 (SCA2). Ataxin-2 is the product of the SCA2 gene which causes familial neurodegenerative diseases. Fox-1 and ataxin-2 are both localized in the trans-Golgi network. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 16-7579839-A-G is Benign according to our data. Variant chr16-7579839-A-G is described in ClinVar as [Benign]. Clinvar id is 415961.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.79 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00987 (1502/152228) while in subpopulation SAS AF= 0.0185 (89/4822). AF 95% confidence interval is 0.0154. There are 12 homozygotes in gnomad4. There are 739 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1502 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBFOX1 | NM_018723.4 | c.333A>G | p.Glu111= | synonymous_variant | 6/16 | ENST00000550418.6 | NP_061193.2 | |
RBFOX1 | NM_145893.3 | c.393A>G | p.Glu131= | synonymous_variant | 3/14 | ENST00000355637.9 | NP_665900.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBFOX1 | ENST00000550418.6 | c.333A>G | p.Glu111= | synonymous_variant | 6/16 | 1 | NM_018723.4 | ENSP00000450031 | A1 | |
RBFOX1 | ENST00000355637.9 | c.393A>G | p.Glu131= | synonymous_variant | 3/14 | 1 | NM_145893.3 | ENSP00000347855 |
Frequencies
GnomAD3 genomes AF: 0.00989 AC: 1505AN: 152110Hom.: 12 Cov.: 32
GnomAD3 genomes
AF:
AC:
1505
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0131 AC: 3278AN: 251056Hom.: 47 AF XY: 0.0142 AC XY: 1924AN XY: 135662
GnomAD3 exomes
AF:
AC:
3278
AN:
251056
Hom.:
AF XY:
AC XY:
1924
AN XY:
135662
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0118 AC: 17254AN: 1461800Hom.: 160 Cov.: 31 AF XY: 0.0122 AC XY: 8879AN XY: 727200
GnomAD4 exome
AF:
AC:
17254
AN:
1461800
Hom.:
Cov.:
31
AF XY:
AC XY:
8879
AN XY:
727200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00987 AC: 1502AN: 152228Hom.: 12 Cov.: 32 AF XY: 0.00993 AC XY: 739AN XY: 74442
GnomAD4 genome
AF:
AC:
1502
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
739
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
26
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 05, 2017 | - - |
Idiopathic generalized epilepsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at